CINXE.COM

<!DOCTYPE html><html lang="en-US"><head><title>Just a moment...</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="robots" content="noindex,nofollow"><meta name="viewport" content="width=device-width,initial-scale=1"><style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width <= 720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width <= 720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}</style><meta http-equiv="refresh" content="120"></head><body class="no-js"><div class="main-wrapper" role="main"><div class="main-content"><noscript><div class="h2"><span id="challenge-error-text">Enable JavaScript and cookies to continue</span></div></noscript></div></div><script>(function(){window._cf_chl_opt={cvId: '3',cZone: "publications.waset.org",cType: 'non-interactive',cRay: '913415186b383f95',cH: 'l2S5ESLuHoZAUlP5MqgSgPDSPfFTkDB0inIxAkG0_Qg-1739777534-1.2.1.1-MJSJIYw.HQoIyh9zX3aCyOghRXrnIGnBzs90sZKxyJB7MyxFM3HsL_vJEsyTqTIb',cUPMDTk: "\/abstracts\/search?q=polyclonal%20antibodies&__cf_chl_tk=cYZujI75NQfPuQx0ujKQDRHBwVE_zGFXeq9QQ2niRfo-1739777534-1.0.1.1-DjdcrZMTQDCiX_835JicQ8O6Je_NW4A.oqnrdobSmGg",cFPWv: 'b',cITimeS: '1739777534',cTTimeMs: '1000',cMTimeMs: '120000',cTplC: 0,cTplV: 5,cTplB: 'cf',cK: "",fa: "\/abstracts\/search?q=polyclonal%20antibodies&__cf_chl_f_tk=cYZujI75NQfPuQx0ujKQDRHBwVE_zGFXeq9QQ2niRfo-1739777534-1.0.1.1-DjdcrZMTQDCiX_835JicQ8O6Je_NW4A.oqnrdobSmGg",md: "EgCWBcPjjf0s4wLTBrwcZjNUCpN61yYvYz6uYLrBsi0-1739777534-1.2.1.1-gCAM0l6ZnO9b8xKfLzh7Q1dhPtx_ZYoIPa2F32fQ9jq6ojCYS2LT756DHzOCtL_a5xI9bQe_KB9X9iBHKdZuGGzwKNu5jN013AQ0eoZTZSTYKChlWEYNXduuYiuuXwfjBekAKN1k21sy3NYUOuX1IaAsWRtk4TD3TNcTXkr39D9ZjP8ErI3aE13rBEDZKxKZw6u.SNeZ32jxRZdPPCbM1_qj3MuQEQMbkBzsjhs.fSyPnVk8R8aUXobq1_N1c3VmOnA5eUjR3eAysK7UA9EazUhQrHGeuE53_n.ef0jVQ0RWc.7N6.VSnR3GRO5GQmFd2NUrPVKxEWhsJvHf7dt0gCYY18BJlSgVyuUZEi8VY5BCmh6yi8Bwf71dw09rhWpPajtXalRyGWBlfTsAo2eKcKdeF.1ejY3SOJg9M8Gi7CmW219s09Zan_.PYkY8m9tWo2r92BRfK6wR8Alb2Cfy9_diRvk29vn6B.MjxAGtwVcI1IH9eYCKlsq_o.nTqa46faOHTKvHGVHRFrQO4MUL.3ZU.BiRD8Esy732II88DEMJvbYuT481xoPQF7etkMgMyWu4oTFNeK7bghUbK7F5pE6Owqct3216U4BKc3KuAtPC.tMbhiJQBZAw9F55Wf8KADr27ZUEeAD3VK1LnqK4Xn8DafTIzovxvAfdK0O0UDN63ZznrAHwec4ZkHYczovChueowvlOWTqcl_9HesgO25OCvgv6wJv0R5d79QTuMq9lxon4XWC3hBAqP4D.QchY4gnUbX4375FJ_5cmki3Hbyke4hhCfmaunzLLx4T5Pa9ifnfVJY9aZTSHe6p49gRy8gEsD3W0BxTCjOXfiCgQli6tCsFCd1pXeBx.VozTilBjvvbCzeba7CkaQkz5aFZKd.P_bXpqLIZTfqgIqVgCelCa0DZS4bQmoaFN5WxeG.y1p1z81Imh6QG.ZKksgIljxonbO3QbX7RkxDSYgpw0G4pqSVS4h1PDvc5kark7u293FePgUi.5qVjH6l2YMRYUMBiMoSTKytvyRrOaglxVxNDqrA1IVSKbwyoGmFIDkFAM1oZHzyr6a0yMsAZ2NUfpCDB6p3NSqUuBykorK0m68aQYJsSlex_m4t41viCps5MijpGbyoUeOjdM_cWc1b7HfbanJ3U3xXjPDMhRGrFi_zflEZP7RcQ9I2JOWSbwaYig9cXVcA4CWgW4f3tzWji9DA0Ni__88Vm7n2T.LwXg4UoTDIw4eLcB4bRlD_tY64CmLBIClrwgA2gtjD5h.zcoqaqavFG1XVmVI7eacg2KyBI2bCyNYnJ5ndLqWuQ02JLm4WYgrQUd.eGFYMwoRt.GWtLtS6TawskniWSe7p2Vvrv9tY3gIxl1AFVmUe9eRF7mspHGsPzEqPJWGbNK0EI1lgXW3q4koYzVieJUlNnJGxdcyv4cN4Z0zXle.tATpYNOGGgOnepOVr8mHDV5H8bQN25X.EMq3x8hqeQHuyxw_Gq8GZfOJhiyYsJaOWi821UihCyVGdFF2sWDUhd3Znkdb6XBj06CZSRW_M9SV6.aXQx.5_hU1ZLmeLxT_MNahVD2_WebxcZsCun_m7P7G24yVjawSf0o_rfC7ojzu0lgPuj9FtLsCmsl7GGkCJAmiWK26LxbUyf15V8YzY01b9imqpFhsFuzx9xh5gUwlDtOOUeamLtAMxrfndprcO9LMjuqKaHvT_FI8fTz.yOsuVchbM7ca_mwdk8.m7vHQzcMC4IaXj0Qzx42qwpEba2n4sW_zKxbhCz44Qk.SYRuV2SUALnz78No3QyDC2KqDak_ehXzrKhJDoPJ93nEg2VEz31bqxj1QXROoMRPV7_IQOp1e4K29ysTp9cFJKWecE_bCSzMzSTIMhiSAHSgtbmX554I1LGU2mBpWeS.BJWhZ0hrpPN7PSADoTxFughQE8rlHz.Vpz2QSuOihmOTfVTMWqx.QAW7FGXSX5JTB2X.nk3c",mdrd: "OfcKCpW2ov9ZEFoJfNwFR6pTiywaxMRIlIozJIQTo2s-1739777534-1.2.1.1-5FdczAzee1vjkPPulwS3WIfY_BTF95F3yoDp9tE8QnwGz3e7_mQ2HlAjIuJMrq2EZDM1.3tNmZRc3AQBEAsxbfxGnYxb4p0.KZs18UJLI0GwH_U0a8Ocrp9rDZLZ_.Nc1hQMMjxL0L6T6v3D5dUnmRFYusDjzSDluD711o42Dv9WjXOeXwgrwnhvW5gPIeqalHNYIEeZLcmdtulP4_8Ym7.2UHprioRWnsjb2SPbQ9bczscM7UAd8EEI01aQWgcvQ0ROXiKR9NDILk..Y1wrhD2iaswXX4ciFsUrgBx.2D1ztgcLKhZrN0au.8MaqKM_3ZzRSh7.t38klY1SC5A03P18ioQ79ZYgofb0899oVV9olj1Xpd2yJ1cEEzNbVPvhi1TkAuA2QygK1FfBsXajK0oqbE8AVFdUB2CWQgK_q1Kwmqc1cZGYBXl6H3J0T56NJZMXjxBR_TEH9pyW94BWWYI5YroganQPk37RxijPEnCrL2HD1QoRdHiZALPAHrIsziEOta3w3_UZ2a_RDopdp1Z61HQcu20UA_scDIdrWOLo0DgB.1emue4ZFIjqzlPRqAorJTINN1UISefe.NvUNp6k2U_5HYb1jqHUj3Kp4GZJOCHlVR6xAJmjkK2VXb179r4wZW4VsT_bNA7D6_DqXNO7k3r71bHA2j4dDiePD1c.8s9lZvVkHMCKBuBJmuj7gU5emkAcnsz57kIHv6CSACpx9o5ZRVtbWaNtaozdFR5csm724onA.8oR8K5qBnyPsb6936t4aKrL48.Zuq5uUlA4KNtBaUEaVv2Urv.o2Hkv3srCbrOgpCvdkQF_yV27p6CPVo82PTQMnGRrL6GkG5Ya0BoafR1mrbOSIqZEiYrNLTBIrhxRi6o5TOwFPLXNbACyKK3ZWIt4YOMWsyuJ6GP1gXvUN5Zt2u2Aa445bEieHNf2Fmb.WNsJbqBnxukTYbRwyUSL96L0WpDY8cpGKHeQO6bEClH8WFCgGXJT_MYl8rQDX3eAFYZJJs7pHMzFCyMM6GMPP8_CpgR.GqLtK1iAKBBDTTPY7WU50rE1KEuyJTk1nynGnG9Tp4ll9BHXnVwmekoa4i2qaLQ0xXWgpFbL7Jv.UeA2PBYOLN4RvHcTDOPssRRDNAm09aQ.8viCV1B3_vlgleP482pji6qrDbLa_WOb1Vr2ITd2bot3cdo8N7aN8ds1LNfuplGQUhwDjtFnqeBWTbiE8fObEqwp40169JsvKYIrdy1f1lDFURkVFFHOxmNhCnKcjeFgvfKlEkTPYbnPIMPk8.EmD5Nc6ipCuH6qnExTEldhEbwelmDaoowA3Io7MKhuiwmzJRnHyHYWf.WCIdaNJKlmTtdYKqR1vMkLWg2mAEGHwJC5UOMLpPo.jkRneUNGEiNU5oGoO9uk6RGHbIiauE5Ha95P.JEkXHHVbyf.t7XTQNvGGrWVRFCgH_26eiP_B7quM3xI_9skCF9n4_coZ7AFXNG8sw9vgx0WZYgeHUYaWElZ5w70LL6dyQn0cUVwwdISGQoV4OISJIT0.2E5tdeRNnJ8nceJLa.2u5MRoFK1zx9BOONXJkJVsVeiwUG4r.ib4G1YNOEAVeNYQXX2NDs7tJkvGjG5J5R46NrxvQYnri3K2P3KW5C489UA53mv3Pr2sOd5xx_rrKsTetmk8ShIgX3ySTqLO2prXLM4YY9B1.LTWSYhnQUEA3o8MbYVDSrVDDfRSem867uO2XsFqpeNM1E9h0cfCbrohh_fsZhonzafJfEjJfixUGFL4q8BMb5CFGEd_KozExfU5pBbTwT.3a7Uw5eYZjbtpeKXMVT7sG_vgZxlzFLXhSNuTEXugvWw9.2K8t3kCT7Km4wNQ3A0_G1etdsG2Tvcqt3QtrFuaY_IeTWBTWUULiZQx6ryULPnQFoWYtaqsCgR6cuv6p.xEe_f9rbXqaSFLxOplJGZsgkTfCDp0qey90dN6e0fCxEbSL95OZ60b1hn2ShP3vytzu9PZA"};var cpo = document.createElement('script');cpo.src = '/cdn-cgi/challenge-platform/h/b/orchestrate/chl_page/v1?ray=913415186b383f95';window._cf_chl_opt.cOgUHash = location.hash === '' && location.href.indexOf('#') !== -1 ? '#' : location.hash;window._cf_chl_opt.cOgUQuery = location.search === '' && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf('?') !== -1 ? '?' : location.search;if (window.history && window.history.replaceState) {var ogU = location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, "\/abstracts\/search?q=polyclonal%20antibodies&__cf_chl_rt_tk=cYZujI75NQfPuQx0ujKQDRHBwVE_zGFXeq9QQ2niRfo-1739777534-1.0.1.1-DjdcrZMTQDCiX_835JicQ8O6Je_NW4A.oqnrdobSmGg" + window._cf_chl_opt.cOgUHash);cpo.onload = function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName('head')[0].appendChild(cpo);}());</script></body></html>